Literature DB >> 28501282

Proteinuria in preeclampsia: Not essential to diagnosis but related to disease severity and fetal outcomes.

Xin Dong1, Wenli Gou1, Chunfang Li1, Min Wu1, Zhen Han1, Xuelan Li2, Qi Chen3.   

Abstract

Preeclampsia is a leading cause of maternal and perinatal morbidity and mortality globally and proteinuria can be one of the cardinal features of this disease. However, studies about the association of the amount of proteinuria and the severity of preeclampsia, and perinatal outcomes are limited. Data on 239 women with preeclampsia were retrospectively collected from a university teaching hospital from September 2011 to June 2013 and analysed. Data included all clinical parameters and proteinuria in a 24h urine collection. In cases of severe preeclampsia, significantly fewer patients had proteinuria levels <0.3g/L in comparison to any of the other groups with proteinuria >0.3g/L, but there was no difference in cases of severe preeclampsia when proteinuria levels were >0.3g/L. Furthermore, when proteinuria levels were >0.3g/L, the frequency of severe preeclampsia in each group was significantly higher than the frequency of mild pre-eclampsia cases. Time of onset was significantly earlier in patients with proteinuria >3g/L in a 24h urine collection, but time between the onset of preeclampsia and delivery was not correlated with the amount of proteinuria. The birth weight was significantly lower in patients with proteinuria >3g/L. The incidence of fetal growth restriction or stillbirth was significantly higher in patients with proteinuria >5g/L. Our data demonstrate that the amount of proteinuria is not associated with the severe of preeclampsia, once proteinuria is detected, but is related to the severity of preeclampsia. The adverse fetal outcomes appear to be the function of prematurity rather than proteinuria itself.
Copyright © 2017 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fetal outcomes; Preeclampsia; Proteinuria; Severity

Mesh:

Year:  2017        PMID: 28501282     DOI: 10.1016/j.preghy.2017.03.005

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  6 in total

1.  Expectant or outpatient management of preeclampsia before 34 weeks: safe for mother but associated with increased stillbirth risk.

Authors:  Jing Fu; Chunfang Li; Wenli Gou; Arier Lee; Xuelan Li; Qi Chen
Journal:  J Hum Hypertens       Date:  2019-02-11       Impact factor: 3.012

2.  The cerebroplacental ratio: association with maternal hypertension and proteinuria.

Authors:  Oluwatoyin Ige Oyekale; Temitope Olugbenga Bello; Oluwagbemiga Ayoola; Adeola Afolabi; Olayemi Atinuke Alagbe; Oluwalana Timothy Oyekale; Oluwatoyin Nike Akinyoade
Journal:  Radiol Bras       Date:  2021 Nov-Dec

3.  Serum From Preeclamptic Women Triggers Endoplasmic Reticulum Stress Pathway and Expression of Angiogenic Factors in Trophoblast Cells.

Authors:  Karla R Castro; Karen M Prado; Aline R Lorenzon; Mara S Hoshida; Eliane A Alves; Rossana P V Francisco; Marcelo Zugaib; Aldilane L X Marques; Elaine C O Silva; Eduardo J S Fonseca; Alexandre U Borbely; Mariana M Veras; Estela Bevilacqua
Journal:  Front Physiol       Date:  2022-02-04       Impact factor: 4.566

4.  The association between protein levels in 24-hour urine samples and maternal and neonatal outcomes of pregnant women with preeclampsia.

Authors:  Gülşah Aynaoğlu Yıldız; Emsal Pınar Topdağı Yılmaz
Journal:  J Turk Ger Gynecol Assoc       Date:  2022-09-05

5.  Developmental Vitamin D Deficiency in Pregnant Rats Does Not Induce Preeclampsia.

Authors:  Asad Ali; Suzanne Alexander; Pauline Ko; James S M Cuffe; Andrew J O Whitehouse; John J McGrath; Darryl Eyles
Journal:  Nutrients       Date:  2021-11-26       Impact factor: 5.717

6.  Diagnosis of proteinuria using a random urine protein-creatinine ratio and its correlation with adverse outcomes in pregnancy with preeclampsia characterized by renal damage.

Authors:  Jiangbo Xiao; Weimin Fan; Qingyi Zhu; Zhonghua Shi
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-03-25       Impact factor: 2.885

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.